An endovascular system includes inner and outer catheters, a handle system operably coupled one end of the catheters, and a microvalve coupled to the other end of the catheters. The microvalve is constrained in a radially-collapsed closed configuration for advancement within a vessel to a treatment site. The handle system is operable to displace the inner and outer catheters portions relative to each other to move the microvalve between closed and open configurations. An indicator is provided to visually indicate the extent by which the microvalve is opened within the vessel.

A minimally invasive system for monitoring and treating high intracranial pressure levels resulting from traumatic brain injury comprises an intravenous access device, an elongate member, a console, and an aspiration and injection catheter. The system is capable of monitoring pressure levels and relocating fluid from the brain to another part of the patient's body to sustain overall constant fluid volume. The method of using the minimally invasive system is also described.

Left atrial appendage (LAA) occlusion device including a membrane, a plurality of fixation splines and a deployment hub, the plurality of fixation splines for affixing the LAA occlusion device to an ostium of the LAA, the deployment hub being positioned in the membrane, the deployment hub including a threaded aperture and a one-way valve, for enabling a toxin to be entered into the LAA through the deployment hub.

A medical device and methods of use are disclosed herein. The medical device includes a base microcatheter and a microcatheter tip assembly detachably coupled to a first end of the base microcatheter. The microcatheter tip assembly includes a body defining at least one lateral hole and a loading region, and an opening in a first end of the microcatheter tip assembly. The medical device includes a membrane carrier disposed within the loading region of the microcatheter tip assembly. The membrane carrier includes a body defining an opening, and a membrane covering the opening in the membrane carrier. The membrane is configured to rupture in response to a force applied to the membrane. When the membrane is disposed within the loading region of the microcatheter tip assembly and the membrane is not ruptured, the membrane is configured to prevent the flow of material through the opening in the first end of the microcatheter tip assembly.

A delivery tube and cap are configured to be connected to a container that houses fluid to be delivered to a nasal cavity. The delivery tube includes an inner cannula that is positioned within an outer cannula. Each of the cannulas includes an outlet. The delivery tube and cap are configured to provide relative axial movement between the cannulas. The cannulas are positionable between a first axial position that aligns the outlets to deliver the fluid out of the device in a lateral direction and a second axial position that misaligns the outlets to impede the fluid from being delivered out of the device in the lateral direction.

A clot removal system comprises a catheter, a vacuum source, and a controller. The catheter comprises a proximal end, a distal end, and controller operating parameters and defines a lumen configured to be filled with a liquid column having a proximal portion. The vacuum source is configured to supply vacuum. The controller is configured to carry out a control pattern of turning on and off the vacuum based upon the controller operating parameters and is configured to receive the controller operating parameters in an automatic response to the catheter being operatively connected to at least one of the vacuum source and the controller and, responsive to the connection, to carry out the control pattern to change a level of vacuum at the distal end of the catheter.

A catheter device for repositioning or explanting an implantable medical device comprises an outer catheter, and a steerable catheter extending through the outer catheter, wherein the outer catheter is axially movable with respect to the steerable catheter. A snare catheter extends through the steerable catheter, wherein the snare catheter is axially movable relative to the steerable catheter. A mandrel may extend through the snare catheter and comprising a distal end, wherein the mandrel is axially movable relative to the snare catheter. A snare may be arranged on the distal end of the mandrel for establishing a connection to the implantable medical device, wherein the snare, by moving the mandrel with respect to the snare catheter, is at least partially retractable into the snare catheter.

An illustrative drug delivery system implantable in a recipient may include a connection assembly, a source catheter, and a microcatheter. A proximal end portion of the source catheter may be configured to be fluidically connected to a fluid source configured to provide a fluid (e.g., a neurotherapeutic drug). A distal end portion of the source catheter may be configured to be fluidically connected to the connection assembly. The microcatheter may include a proximal end portion configured to be fluidically connected to the connection assembly and a distal end portion comprising an elution opening configured to elute the fluid to a target location (e.g., a brain) within a recipient. The fluid source may be configured to provide the fluid to the target location by way of the source catheter, the connection assembly, and the microcatheter.

An everting balloon system is disclosed that can be used for the placement of an IUD within the uterine cavity of a female patient. The everting balloon system with IUD can be used to access a uterine cavity at specific locations in the fundus. A one-handed IUD delivery system for placement with an everting catheter is disclosed. An IUD loading system for placement within an everting catheter is disclosed. The everting catheter with an IUD can simplify the process of IUD placement within the uterine cavity.

Disclosed herein are vascular access systems with dilator locking mechanisms, and associated devices and methods. In some embodiments, the dilator locking mechanisms include a first cap coupled to a dilator component and a second cap coupled to the vascular access system. The first cap can include one or more locking members. The second cap can include one or more locking features, each configured to be releasably coupled to one of the locking members. In operation, the dilator component can be inserted into the vascular access system, and at least a portion of one or more of the locking members can be aligned with and inserted into the corresponding locking feature to, e.g., couple the first cap and the second cap. The interaction between first and second caps when coupled can at least partially prevent the dilator from moving relative to the vascular access system.